Who owns Covance?
Covance is a global contract research organization and drug development services company. They also offer laboratory testing services to the chemical, agrochemical, and food industries and are a market leader in toxicology services, central laboratory services, discovery services, and a top global provider of Phase III clinical trial management services. Who owns Covance? Covance Inc….
Covance is a global contract research organization and drug development services company. They also offer laboratory testing services to the chemical, agrochemical, and food industries and are a market leader in toxicology services, central laboratory services, discovery services, and a top global provider of Phase III clinical trial management services.
Who owns Covance?
Covance Inc. provides early-and late-stage services to the pharmaceutical, biotechnology, and medical device industries. Its early-stage development services include preclinical and clinical pharmacology services. The company’s late-stage services include biomarker services to biotech and pharmaceutical customers, with full management of PhaseII and III clinical studies. It also provides lab testing services to the chemical, agrochemical, and food industries. The company was founded in 1987 and is based in Princeton, N.J.
Covance was acquired by LabCorp for $5.6B on Nov 3, 2014. Covance, the drug development business of Laboratory Corporation of America Holdings (LabCorp), is the world’s most comprehensive drug development company, dedicated to advancing healthcare and delivering Solutions Made Real by providing high-quality nonclinical, clinical, and commercialization services to pharmaceutical and biotechnology companies to help reduce the time and costs associated with drug development.
